MUC1 and esophageal cancer: This evidence supports that MUC1 can be considered as an early diagnostic biomarker (lung adenocarcinoma [236], pancreatic [237,238], or ovarian [239] cancer) or as a prognostic biomarker (bladder carcinoma [240], node-negative breast [241], lung squamous cell [242], and esophageal cancer [243].